Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Ishitani

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Internal Medicine (Tokyo, Japan)|January 5, 2002
Successful treatment of a case of relapsed acute promyelocytic leukemia with arsenic trioxideY Hirayama, R Koyama, T Nagai, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1994
[Phase I clinical trial of RP 56976 (docetaxel) a new anticancer drug]T Taguchi, H Furue, H Niitani, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1985
[Clinical phase II study of 5'-DFUR for cancer of the digestive organs by a cooperative study group]I Urushizaki, Y Kogo, K Kouda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1994
[Antitumor and anticachectic activity of UFT in BALB/c mice bearing colon 26 adenocarcinoma]M Nukatsuka, A Fujioka, H Saito, et al.
Immunogenetics|August 7, 2001
The cell surface-expressed HSC70-like molecule preferentially reacts with the rat T-cell receptor Vdelta6 familyA Kishi, T Ichinohe, I Hirai, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Internal Medicine (Tokyo, Japan)|January 5, 2002
Successful treatment of a case of relapsed acute promyelocytic leukemia with arsenic trioxideY Hirayama, R Koyama, T Nagai, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1994
[Phase I clinical trial of RP 56976 (docetaxel) a new anticancer drug]T Taguchi, H Furue, H Niitani, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1985
[Clinical phase II study of 5'-DFUR for cancer of the digestive organs by a cooperative study group]I Urushizaki, Y Kogo, K Kouda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1994
[Antitumor and anticachectic activity of UFT in BALB/c mice bearing colon 26 adenocarcinoma]M Nukatsuka, A Fujioka, H Saito, et al.
Immunogenetics|August 7, 2001
The cell surface-expressed HSC70-like molecule preferentially reacts with the rat T-cell receptor Vdelta6 familyA Kishi, T Ichinohe, I Hirai, et al.
Pageof 5